Fangzhou Inc. (06086.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenHKD 0.70

From 52W high−85.25%

Volume96000.00

Market capHKD 959.75M

P/E (TTM)—

P/S (TTM)0.2x

Div yield—

Key dataSep 18, 2026

Open

HKD 0.70

From 52W high

−85.25%

Volume

96000.00

Market cap

HKD 959.75M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

46.0x

P/E (TTM)

—

RSI (14)

49.5

MomentumView details →

1D Return

+2.86%

YTD Return

−68.00%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

46.0x

EV/Sales

0.1x

P/S (TTM)

0.2x

P/B (TTM)

2.8x

ProfitabilityView details →

Gross Margin

14.51%

Net Margin

0.21%

EBITDA Margin

0.19%

ROE (TTM)

2.79%

ROA (TTM)

0.85%

Asset Turnover

4.32x

GrowthView details →

Revenue YoY

+34.08%

EPS YoY

+132.79%

FCF YoY

+54.90%

Revenue CAGR 3Y

+16.95%

EPS CAGR 3Y

+101.01%

EBITDA YoY

−1.42%

MomentumView details →

1D Return

+2.86%

YTD Return

−68.00%

1Y Return

−83.45%

RSI (14)

49.5

vs 50D SMA

−1.11%

vs 200D SMA

−53.36%

Capital & dividendView details →

Debt/Equity

0.08x

Current Ratio

1.40x

Quick Ratio

1.08x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

HKD 0.01

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

−7.19%

Financials snapshotView financials →

Revenue (TTM)

6.74B

Net Income (TTM)

−15.41M

Op. CF (TTM)

63.55M

Next earningsMar 19, 2027 →

Latest newsMore news →

Fangzhou Inc. reported its interim results for the six months ended June 30, 2026, with revenue of RMB1.82 billion, up 22.2% year-over-year, and adjusted net profit of RMB18.7 million, up 6.4%.24d ago

Similar companies

Beijing Biostar Pharms Co Ltd02563.HK TYK Medicines, Inc02410.HK Modern Chinese Medicine Group Co., Ltd.01643.HK 天目药业600671.SH Organon & Co.OGN Impact Therap-b07630.HK Find similar companies →

Latest newsMore news →

Fangzhou Inc. reported its interim results for the six months ended June 30, 2026, with revenue of RMB1.82 billion, up 22.2% year-over-year, and adjusted net profit of RMB18.7 million, up 6.4%.24d ago